Montelukast

National NHS prescribing (Prescription Cost Analysis) · Cromoglycate, leukotriene and phosphodesterase type-4 inhib

Data updated March 2026

Montelukast was ranked 59th of 1,794 medicines by items in March 2026, with 416,237 items, up 3.5% on a year earlier.

416,237items

Dispensed in March 2026

NHSBSA Prescription Cost Analysis

£386,754

Net ingredient cost · March 2026

NHSBSA PCA

4,907,834items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Montelukast: national items dispensed by month

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV

Embed this chart

<iframe src="https://pharmainsight.co.uk/embed/medicines/montelukast-0303020g0" width="100%" height="280" style="border:0" loading="lazy" title="Montelukast: NHS prescribing in England — PharmaInsight"></iframe>

Top presentations, March 2026

The individual products dispensed under Montelukast, by items this month.

Presentations of Montelukast, March 2026
Presentation	Items	Net ingredient cost
Montelukast 10mg tablets	374,393	£300,812
Montelukast 5mg chewable tablets sugar free	29,895	£33,246
Montelukast 4mg chewable tablets sugar free	7,140	£6,369
Montelukast 4mg granules sachets sugar free	4,110	£25,187
Singulair 10mg tablets	661	£19,958
Singulair Paediatric 5mg chewable tablets	30	£848
Singulair Paediatric 4mg chewable tablets	6	£283
Singulair Paediatric 4mg granules sachets	2	£51

Compare Montelukast with

Other medicines in the same BNF section, by prescribing volume.